COMMUNIQUÉS West-GlobeNewswire

Mother’s Day Gifting Is Changing: From Symbolic Presents to Meaningful Relief — Bob and Brad Marks the Occasion with Up to 30% Off Wellness Devices
04/05/2026
WINONA, Minn., May 04, 2026 (GLOBE NEWSWIRE) -- Mother’s Day gifting is undergoing a subtle shift, with more consumers moving beyond traditional symbolic presents toward products that offer practical, everyday relief. [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
04/05/2026
COPENHAGEN, Denmark, May 4, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on March 12, 2026, under which the Company will repurchase shares for an amount up to [...]
Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
04/05/2026
Successful partnership continues as bispecific antibody candidate moves to GMP manufacturing; project highlights Japan's advanced capabilities in bioprocessing and AGC Biologics' expanding global network CHIBA, Japan, [...]
MemoPryl Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk
02/05/2026
MemoPryl Scam Searches, Complaints, and Side Effects Risk Explained for Adults Comparing Nootropic Memory Supplements in 2026 Aurora, CO, May 02, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the [...]
VisioCore Claims Evaluated: The 8-Second Amazonian Morning Flush For Crystal Clear Vision Support
02/05/2026
VisioCore Vision Support Supplement Ingredients, Lutein and Zeaxanthin Formula, Pricing, Official Website Access, and 60-Day Guarantee Explained for 2026 Aurora, CO, May 02, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Halo Care Skin Tag Remover Claims Evaluated: The Strongest, Most Effective Mole & Skin Tag Corrector Serum
02/05/2026
Halo Care Skin Tag Remover Sanguinaria Canadensis and Zincum Muriaticum Formula Explained: 2026 Pricing, Refund, and Dermatologist Guidance New York, NY, May 02, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
Milken Institute Global Conference 2026 Set to Open Tomorrow in Beverly Hills with KFSH Participation
02/05/2026
BEVERLY HILLS, Calif., May 02, 2026 (GLOBE NEWSWIRE) -- The Milken Institute Global Conference 2026 is set to open tomorrow in Beverly Hills, bringing together a global cross section of leaders from healthcare, finance [...]
Avicanna Announces Change in Board of Directors
02/05/2026
TORONTO, May 01, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation [...]
Pennant Acquires Senior Living Communities in Arizona and Wisconsin
02/05/2026
EAGLE, Idaho, May 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today [...]
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
SAN DIEGO, May 01, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as [...]
Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer
01/05/2026
VANCOUVER, British Columbia, May 01, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort
01/05/2026
Detailed data for the gedatolisib triplet and doublet regimens will be presented at a late-breaking abstract oral session at the 2026 ASCO Annual Meeting MINNEAPOLIS, May 01, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. ( [...]
Pacific Health Care Organization, Inc. Reports its First Quarter 2026 Financial Results
01/05/2026
Irvine, California, May 01, 2026 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) filed yesterday with the Securities and Exchange Commission (the “SEC”) its quarterly report on [...]
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
NAARDEN, the Netherlands and MIAMI, May 01, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, [...]
Refills GLP-1 Weight Loss Claims Evaluated: The Most Affordable Personalized Semaglutide & Tirzepatide GLP1 Program with Online Doctor Support
01/05/2026
How Compounded Semaglutide and Tirzepatide Access Works Through a Virtual GLP-1 Program With No Insurance Required in 2026 Wilmington, DE, May 01, 2026 (GLOBE NEWSWIRE) -- Compounded semaglutide and tirzepatide are not [...]
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
LA JOLLA, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that on May 1 [...]
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
01/05/2026
Company advances focused strategy, strengthens balance sheet and positions business for long-term growth FLORHAM PARK, N.J., May 01, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company [...]
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
NEW YORK and WALTHAM, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01/05/2026
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 01, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]

Pages